 | • レポートコード：MR2211M-4010 • 出版社/出版日：Market Monitor Global / 2022年5月 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：医療 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥721,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、救急治療薬のグローバル市場規模と予測を記載しています。・救急治療薬のグローバル市場：売上、2017年-2022年、2023年-2028年 ・救急治療薬のグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 救急治療薬のグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「中枢興奮剤」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 救急治療薬のグローバル主要企業は、GlaxoSmithKline、 Roche、 AbbVie、 Pfizer、 Eli Lilly、 Allergan、 Johnson & Johnson、 Nycomed (Takeda)、 Novartis、 Merck、 AstraZeneca、 Sanofi、 Abbott、 Amgen、 Tillotts Pharma、 Bristol-Myers Squibb Company、 Celgene Corporation、 Alexion Pharmaceuticals, Inc.、 KELUN、 Novo Nordisk A/S、 Eisai Co., Ltd.、 Daiichi Sankyo Companyなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、救急治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の救急治療薬市場：タイプ別、2017年-2022年、2023年-2028年 世界の救急治療薬市場：タイプ別市場シェア、2021年 ・中枢興奮剤、鎮静剤＆精神安定剤、鎮痛剤、ショックに対する薬剤耐性、微小循環薬改善、強心薬、抗不整脈、血管拡張剤、水電解質平衡剤 世界の救急治療薬市場：用途別、2017年-2022年、2023年-2028年 世界の救急治療薬市場：用途別市場シェア、2021年 ・病院、製薬＆バイオテクノロジー企業、外来外科センター＆クリニック、学術＆研究機関、その他 世界の救急治療薬市場：地域・国別、2017年-2022年、2023年-2028年 世界の救急治療薬市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における救急治療薬のグローバル売上、2017年-2022年 ・主要企業における救急治療薬のグローバル売上シェア、2021年 ・主要企業における救急治療薬のグローバル販売量、2017年-2022年 ・主要企業における救急治療薬のグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 GlaxoSmithKline、 Roche、 AbbVie、 Pfizer、 Eli Lilly、 Allergan、 Johnson & Johnson、 Nycomed (Takeda)、 Novartis、 Merck、 AstraZeneca、 Sanofi、 Abbott、 Amgen、 Tillotts Pharma、 Bristol-Myers Squibb Company、 Celgene Corporation、 Alexion Pharmaceuticals, Inc.、 KELUN、 Novo Nordisk A/S、 Eisai Co., Ltd.、 Daiichi Sankyo Company ************************************************************* ・調査・分析レポートの概要 救急治療薬市場の定義 市場セグメント 世界の救急治療薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の救急治療薬市場規模 世界の救急治療薬市場規模：2021年 VS 2028年 世界の救急治療薬市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの救急治療薬の売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業の救急治療薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：中枢興奮剤、鎮静剤＆精神安定剤、鎮痛剤、ショックに対する薬剤耐性、微小循環薬改善、強心薬、抗不整脈、血管拡張剤、水電解質平衡剤 救急治療薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、製薬＆バイオテクノロジー企業、外来外科センター＆クリニック、学術＆研究機関、その他 救急治療薬の用途別グローバル売上・予測 ・地域別市場分析 地域別救急治療薬市場規模 2021年と2028年 地域別救急治療薬売上・予測 北米市場 - アメリカの救急治療薬市場規模2017年-2028年 - カナダの救急治療薬市場規模2017年-2028年 - メキシコの救急治療薬市場規模2017年-2028年 ヨーロッパ市場 - ドイツの救急治療薬市場規模2017年-2028年 - フランスの救急治療薬市場規模2017年-2028年 - イギリスの救急治療薬市場規模2017年-2028年 - イタリアの救急治療薬市場規模2017年-2028年 - ロシアの救急治療薬市場規模2017年-2028年 アジア市場 - 中国の救急治療薬市場規模2017年-2028年 - 日本の救急治療薬市場規模2017年-2028年 - 韓国の救急治療薬市場規模2017年-2028年 - 東南アジアの救急治療薬市場規模2017年-2028年 - インドの救急治療薬市場規模2017年-2028年 南米市場 - ブラジルの救急治療薬市場規模2017年-2028年 - アルゼンチンの救急治療薬市場規模2017年-2028年 中東・アフリカ市場 - トルコの救急治療薬市場規模2017年-2028年 - イスラエルの救急治療薬市場規模2017年-2028年 - サウジアラビアの救急治療薬市場規模2017年-2028年 - UAEの救急治療薬市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） GlaxoSmithKline、 Roche、 AbbVie、 Pfizer、 Eli Lilly、 Allergan、 Johnson & Johnson、 Nycomed (Takeda)、 Novartis、 Merck、 AstraZeneca、 Sanofi、 Abbott、 Amgen、 Tillotts Pharma、 Bristol-Myers Squibb Company、 Celgene Corporation、 Alexion Pharmaceuticals, Inc.、 KELUN、 Novo Nordisk A/S、 Eisai Co., Ltd.、 Daiichi Sankyo Company ... |
This report contains market size and forecasts of Emergency Care Drugs in Global, including the following market information:
Global Emergency Care Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Emergency Care Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Central Excitant Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Emergency Care Drugs include GlaxoSmithKline, Roche, AbbVie, Pfizer, Eli Lilly, Allergan, Johnson & Johnson, Nycomed (Takeda) and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Emergency Care Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Emergency Care Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Emergency Care Drugs Market Segment Percentages, by Type, 2021 (%)
Central Excitant
Sedative and Tranquilizer
Pain Relievers
Drug Resistance to Shock
Improve Microcirculation Medicine
Strong Heart Medicine
Antiarrhythmias
Vasodilator
Water Electrolyte Balancing Agent
Global Emergency Care Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Emergency Care Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Pharmaceutical And Biotechnology Companies
Outpatient Surgical Centers And Clinics
Academic And Research Organizations
Other
Global Emergency Care Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Emergency Care Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Emergency Care Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Emergency Care Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Roche
AbbVie
Pfizer
Eli Lilly
Allergan
Johnson & Johnson
Nycomed (Takeda)
Novartis
Merck
AstraZeneca
Sanofi
Abbott
Amgen
Tillotts Pharma
Bristol-Myers Squibb Company
Celgene Corporation
Alexion Pharmaceuticals, Inc.
KELUN
Novo Nordisk A/S
Eisai Co., Ltd.
Daiichi Sankyo Company Limited
Bayer AG
Biogen, Inc.
Takeda
Huadong Medicine
Dongbao Pharmaceutical
Hisun Pharmacy
KELUN
Ginwa
Tianan Pharmaceutical
Jumpcan Pharmacy
Guangzhou Baiyun Mountain
SHIJIAZHUANG YILING PHARMACEUTICAL
Wanbang Biopharmaceuticals
Gan & Lee
Taloph
1 Introduction to Research & Analysis Reports
1.1 Emergency Care Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Emergency Care Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Emergency Care Drugs Overall Market Size
2.1 Global Emergency Care Drugs Market Size: 2021 VS 2028
2.2 Global Emergency Care Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Emergency Care Drugs Players in Global Market
3.2 Top Global Emergency Care Drugs Companies Ranked by Revenue
3.3 Global Emergency Care Drugs Revenue by Companies
3.4 Top 3 and Top 5 Emergency Care Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Emergency Care Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Emergency Care Drugs Players in Global Market
3.6.1 List of Global Tier 1 Emergency Care Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Emergency Care Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type – Global Emergency Care Drugs Market Size Markets, 2021 & 2028
4.1.2 Central Excitant
4.1.3 Sedative and Tranquilizer
4.1.4 Pain Relievers
4.1.5 Drug Resistance to Shock
4.1.6 Improve Microcirculation Medicine
4.1.7 Strong Heart Medicine
4.1.8 Antiarrhythmias
4.1.9 Vasodilator
4.1.10 Water Electrolyte Balancing Agent
4.2 By Type – Global Emergency Care Drugs Revenue & Forecasts
4.2.1 By Type – Global Emergency Care Drugs Revenue, 2017-2022
4.2.2 By Type – Global Emergency Care Drugs Revenue, 2023-2028
4.2.3 By Type – Global Emergency Care Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Emergency Care Drugs Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Pharmaceutical And Biotechnology Companies
5.1.4 Outpatient Surgical Centers And Clinics
5.1.5 Academic And Research Organizations
5.1.6 Other
5.2 By Application – Global Emergency Care Drugs Revenue & Forecasts
5.2.1 By Application – Global Emergency Care Drugs Revenue, 2017-2022
5.2.2 By Application – Global Emergency Care Drugs Revenue, 2023-2028
5.2.3 By Application – Global Emergency Care Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region – Global Emergency Care Drugs Market Size, 2021 & 2028
6.2 By Region – Global Emergency Care Drugs Revenue & Forecasts
6.2.1 By Region – Global Emergency Care Drugs Revenue, 2017-2022
6.2.2 By Region – Global Emergency Care Drugs Revenue, 2023-2028
6.2.3 By Region – Global Emergency Care Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country – North America Emergency Care Drugs Revenue, 2017-2028
6.3.2 US Emergency Care Drugs Market Size, 2017-2028
6.3.3 Canada Emergency Care Drugs Market Size, 2017-2028
6.3.4 Mexico Emergency Care Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country – Europe Emergency Care Drugs Revenue, 2017-2028
6.4.2 Germany Emergency Care Drugs Market Size, 2017-2028
6.4.3 France Emergency Care Drugs Market Size, 2017-2028
6.4.4 U.K. Emergency Care Drugs Market Size, 2017-2028
6.4.5 Italy Emergency Care Drugs Market Size, 2017-2028
6.4.6 Russia Emergency Care Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Emergency Care Drugs Market Size, 2017-2028
6.4.8 Benelux Emergency Care Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region – Asia Emergency Care Drugs Revenue, 2017-2028
6.5.2 China Emergency Care Drugs Market Size, 2017-2028
6.5.3 Japan Emergency Care Drugs Market Size, 2017-2028
6.5.4 South Korea Emergency Care Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Emergency Care Drugs Market Size, 2017-2028
6.5.6 India Emergency Care Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country – South America Emergency Care Drugs Revenue, 2017-2028
6.6.2 Brazil Emergency Care Drugs Market Size, 2017-2028
6.6.3 Argentina Emergency Care Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Emergency Care Drugs Revenue, 2017-2028
6.7.2 Turkey Emergency Care Drugs Market Size, 2017-2028
6.7.3 Israel Emergency Care Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Emergency Care Drugs Market Size, 2017-2028
6.7.5 UAE Emergency Care Drugs Market Size, 2017-2028
7 Players Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Emergency Care Drugs Major Product Offerings
7.1.4 GlaxoSmithKline Emergency Care Drugs Revenue in Global Market (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Emergency Care Drugs Major Product Offerings
7.2.4 Roche Emergency Care Drugs Revenue in Global Market (2017-2022)
7.2.5 Roche Key News
7.3 AbbVie
7.3.1 AbbVie Corporate Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Emergency Care Drugs Major Product Offerings
7.3.4 AbbVie Emergency Care Drugs Revenue in Global Market (2017-2022)
7.3.5 AbbVie Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Emergency Care Drugs Major Product Offerings
7.4.4 Pfizer Emergency Care Drugs Revenue in Global Market (2017-2022)
7.4.5 Pfizer Key News
7.5 Eli Lilly
7.5.1 Eli Lilly Corporate Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Emergency Care Drugs Major Product Offerings
7.5.4 Eli Lilly Emergency Care Drugs Revenue in Global Market (2017-2022)
7.5.5 Eli Lilly Key News
7.6 Allergan
7.6.1 Allergan Corporate Summary
7.6.2 Allergan Business Overview
7.6.3 Allergan Emergency Care Drugs Major Product Offerings
7.6.4 Allergan Emergency Care Drugs Revenue in Global Market (2017-2022)
7.6.5 Allergan Key News
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Corporate Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Emergency Care Drugs Major Product Offerings
7.7.4 Johnson & Johnson Emergency Care Drugs Revenue in Global Market (2017-2022)
7.7.5 Johnson & Johnson Key News
7.8 Nycomed (Takeda)
7.8.1 Nycomed (Takeda) Corporate Summary
7.8.2 Nycomed (Takeda) Business Overview
7.8.3 Nycomed (Takeda) Emergency Care Drugs Major Product Offerings
7.8.4 Nycomed (Takeda) Emergency Care Drugs Revenue in Global Market (2017-2022)
7.8.5 Nycomed (Takeda) Key News
7.9 Novartis
7.9.1 Novartis Corporate Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Emergency Care Drugs Major Product Offerings
7.9.4 Novartis Emergency Care Drugs Revenue in Global Market (2017-2022)
7.9.5 Novartis Key News
7.10 Merck
7.10.1 Merck Corporate Summary
7.10.2 Merck Business Overview
7.10.3 Merck Emergency Care Drugs Major Product Offerings
7.10.4 Merck Emergency Care Drugs Revenue in Global Market (2017-2022)
7.10.5 Merck Key News
7.11 AstraZeneca
7.11.1 AstraZeneca Corporate Summary
7.11.2 AstraZeneca Business Overview
7.11.3 AstraZeneca Emergency Care Drugs Major Product Offerings
7.11.4 AstraZeneca Emergency Care Drugs Revenue in Global Market (2017-2022)
7.11.5 AstraZeneca Key News
7.12 Sanofi
7.12.1 Sanofi Corporate Summary
7.12.2 Sanofi Business Overview
7.12.3 Sanofi Emergency Care Drugs Major Product Offerings
7.12.4 Sanofi Emergency Care Drugs Revenue in Global Market (2017-2022)
7.12.5 Sanofi Key News
7.13 Abbott
7.13.1 Abbott Corporate Summary
7.13.2 Abbott Business Overview
7.13.3 Abbott Emergency Care Drugs Major Product Offerings
7.13.4 Abbott Emergency Care Drugs Revenue in Global Market (2017-2022)
7.13.5 Abbott Key News
7.14 Amgen
7.14.1 Amgen Corporate Summary
7.14.2 Amgen Business Overview
7.14.3 Amgen Emergency Care Drugs Major Product Offerings
7.14.4 Amgen Emergency Care Drugs Revenue in Global Market (2017-2022)
7.14.5 Amgen Key News
7.15 Tillotts Pharma
7.15.1 Tillotts Pharma Corporate Summary
7.15.2 Tillotts Pharma Business Overview
7.15.3 Tillotts Pharma Emergency Care Drugs Major Product Offerings
7.15.4 Tillotts Pharma Emergency Care Drugs Revenue in Global Market (2017-2022)
7.15.5 Tillotts Pharma Key News
7.16 Bristol-Myers Squibb Company
7.16.1 Bristol-Myers Squibb Company Corporate Summary
7.16.2 Bristol-Myers Squibb Company Business Overview
7.16.3 Bristol-Myers Squibb Company Emergency Care Drugs Major Product Offerings
7.16.4 Bristol-Myers Squibb Company Emergency Care Drugs Revenue in Global Market (2017-2022)
7.16.5 Bristol-Myers Squibb Company Key News
7.17 Celgene Corporation
7.17.1 Celgene Corporation Corporate Summary
7.17.2 Celgene Corporation Business Overview
7.17.3 Celgene Corporation Emergency Care Drugs Major Product Offerings
7.17.4 Celgene Corporation Emergency Care Drugs Revenue in Global Market (2017-2022)
7.17.5 Celgene Corporation Key News
7.18 Alexion Pharmaceuticals, Inc.
7.18.1 Alexion Pharmaceuticals, Inc. Corporate Summary
7.18.2 Alexion Pharmaceuticals, Inc. Business Overview
7.18.3 Alexion Pharmaceuticals, Inc. Emergency Care Drugs Major Product Offerings
7.18.4 Alexion Pharmaceuticals, Inc. Emergency Care Drugs Revenue in Global Market (2017-2022)
7.18.5 Alexion Pharmaceuticals, Inc. Key News
7.19 KELUN
7.19.1 KELUN Corporate Summary
7.19.2 KELUN Business Overview
7.19.3 KELUN Emergency Care Drugs Major Product Offerings
7.19.4 KELUN Emergency Care Drugs Revenue in Global Market (2017-2022)
7.19.5 KELUN Key News
7.20 Novo Nordisk A/S
7.20.1 Novo Nordisk A/S Corporate Summary
7.20.2 Novo Nordisk A/S Business Overview
7.20.3 Novo Nordisk A/S Emergency Care Drugs Major Product Offerings
7.20.4 Novo Nordisk A/S Emergency Care Drugs Revenue in Global Market (2017-2022)
7.20.5 Novo Nordisk A/S Key News
7.21 Eisai Co., Ltd.
7.21.1 Eisai Co., Ltd. Corporate Summary
7.21.2 Eisai Co., Ltd. Business Overview
7.21.3 Eisai Co., Ltd. Emergency Care Drugs Major Product Offerings
7.21.4 Eisai Co., Ltd. Emergency Care Drugs Revenue in Global Market (2017-2022)
7.21.5 Eisai Co., Ltd. Key News
7.22 Daiichi Sankyo Company Limited
7.22.1 Daiichi Sankyo Company Limited Corporate Summary
7.22.2 Daiichi Sankyo Company Limited Business Overview
7.22.3 Daiichi Sankyo Company Limited Emergency Care Drugs Major Product Offerings
7.22.4 Daiichi Sankyo Company Limited Emergency Care Drugs Revenue in Global Market (2017-2022)
7.22.5 Daiichi Sankyo Company Limited Key News
7.23 Bayer AG
7.23.1 Bayer AG Corporate Summary
7.23.2 Bayer AG Business Overview
7.23.3 Bayer AG Emergency Care Drugs Major Product Offerings
7.23.4 Bayer AG Emergency Care Drugs Revenue in Global Market (2017-2022)
7.23.5 Bayer AG Key News
7.24 Biogen, Inc.
7.24.1 Biogen, Inc. Corporate Summary
7.24.2 Biogen, Inc. Business Overview
7.24.3 Biogen, Inc. Emergency Care Drugs Major Product Offerings
7.24.4 Biogen, Inc. Emergency Care Drugs Revenue in Global Market (2017-2022)
7.24.5 Biogen, Inc. Key News
7.25 Takeda
7.25.1 Takeda Corporate Summary
7.25.2 Takeda Business Overview
7.25.3 Takeda Emergency Care Drugs Major Product Offerings
7.25.4 Takeda Emergency Care Drugs Revenue in Global Market (2017-2022)
7.25.5 Takeda Key News
7.26 Huadong Medicine
7.26.1 Huadong Medicine Corporate Summary
7.26.2 Huadong Medicine Business Overview
7.26.3 Huadong Medicine Emergency Care Drugs Major Product Offerings
7.26.4 Huadong Medicine Emergency Care Drugs Revenue in Global Market (2017-2022)
7.26.5 Huadong Medicine Key News
7.27 Dongbao Pharmaceutical
7.27.1 Dongbao Pharmaceutical Corporate Summary
7.27.2 Dongbao Pharmaceutical Business Overview
7.27.3 Dongbao Pharmaceutical Emergency Care Drugs Major Product Offerings
7.27.4 Dongbao Pharmaceutical Emergency Care Drugs Revenue in Global Market (2017-2022)
7.27.5 Dongbao Pharmaceutical Key News
7.28 Hisun Pharmacy
7.28.1 Hisun Pharmacy Corporate Summary
7.28.2 Hisun Pharmacy Business Overview
7.28.3 Hisun Pharmacy Emergency Care Drugs Major Product Offerings
7.28.4 Hisun Pharmacy Emergency Care Drugs Revenue in Global Market (2017-2022)
7.28.5 Hisun Pharmacy Key News
7.29 KELUN
7.29.1 KELUN Corporate Summary
7.29.2 KELUN Business Overview
7.29.3 KELUN Emergency Care Drugs Major Product Offerings
7.29.4 KELUN Emergency Care Drugs Revenue in Global Market (2017-2022)
7.29.5 KELUN Key News
7.30 Ginwa
7.30.1 Ginwa Corporate Summary
7.30.2 Ginwa Business Overview
7.30.3 Ginwa Emergency Care Drugs Major Product Offerings
7.30.4 Ginwa Emergency Care Drugs Revenue in Global Market (2017-2022)
7.30.5 Ginwa Key News
7.31 Tianan Pharmaceutical
7.31.1 Tianan Pharmaceutical Corporate Summary
7.31.2 Tianan Pharmaceutical Business Overview
7.31.3 Tianan Pharmaceutical Emergency Care Drugs Major Product Offerings
7.31.4 Tianan Pharmaceutical Emergency Care Drugs Revenue in Global Market (2017-2022)
7.31.5 Tianan Pharmaceutical Key News
7.32 Jumpcan Pharmacy
7.32.1 Jumpcan Pharmacy Corporate Summary
7.32.2 Jumpcan Pharmacy Business Overview
7.32.3 Jumpcan Pharmacy Emergency Care Drugs Major Product Offerings
7.32.4 Jumpcan Pharmacy Emergency Care Drugs Revenue in Global Market (2017-2022)
7.32.5 Jumpcan Pharmacy Key News
7.33 Guangzhou Baiyun Mountain
7.33.1 Guangzhou Baiyun Mountain Corporate Summary
7.33.2 Guangzhou Baiyun Mountain Business Overview
7.33.3 Guangzhou Baiyun Mountain Emergency Care Drugs Major Product Offerings
7.33.4 Guangzhou Baiyun Mountain Emergency Care Drugs Revenue in Global Market (2017-2022)
7.33.5 Guangzhou Baiyun Mountain Key News
7.34 SHIJIAZHUANG YILING PHARMACEUTICAL
7.34.1 SHIJIAZHUANG YILING PHARMACEUTICAL Corporate Summary
7.34.2 SHIJIAZHUANG YILING PHARMACEUTICAL Business Overview
7.34.3 SHIJIAZHUANG YILING PHARMACEUTICAL Emergency Care Drugs Major Product Offerings
7.34.4 SHIJIAZHUANG YILING PHARMACEUTICAL Emergency Care Drugs Revenue in Global Market (2017-2022)
7.34.5 SHIJIAZHUANG YILING PHARMACEUTICAL Key News
7.35 Wanbang Biopharmaceuticals
7.35.1 Wanbang Biopharmaceuticals Corporate Summary
7.35.2 Wanbang Biopharmaceuticals Business Overview
7.35.3 Wanbang Biopharmaceuticals Emergency Care Drugs Major Product Offerings
7.35.4 Wanbang Biopharmaceuticals Emergency Care Drugs Revenue in Global Market (2017-2022)
7.35.5 Wanbang Biopharmaceuticals Key News
7.36 Gan & Lee
7.36.1 Gan & Lee Corporate Summary
7.36.2 Gan & Lee Business Overview
7.36.3 Gan & Lee Emergency Care Drugs Major Product Offerings
7.36.4 Gan & Lee Emergency Care Drugs Revenue in Global Market (2017-2022)
7.36.5 Gan & Lee Key News
7.37 Taloph
7.37.1 Taloph Corporate Summary
7.37.2 Taloph Business Overview
7.37.3 Taloph Emergency Care Drugs Major Product Offerings
7.37.4 Taloph Emergency Care Drugs Revenue in Global Market (2017-2022)
7.37.5 Taloph Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer